MORAN TIMOTHY P. (Chief Business Officer) sold 18.7% of their position (15.26K shares) of KESTRA MEDICAL TECHNOLOGIES, LTD. on the open market
Open‑market sale worth $348.3K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/3/2026ACC: 0001193125-26-331066
Officer· Chief Business Officer
Since Nov 2025
-15.26K
Net shares
Net seller
$348.3K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
15.26K disposed
Non-Derivative Transactions3
Common Shares
Direct
Shares
−4.12K
Price / share
$22.77
Trade value
$93.76K
% of position
5.0%
7/30/2026
81.60K→77.48K
Common Shares
Direct
Shares
−8.76K
Price / share
$22.61
Trade value
$198K
% of position
11.3%
7/31/2026
77.48K→68.72K
Common Shares
Direct
Shares
−2.38K
Price / share
$23.76
Trade value
$56.55K
% of position
3.5%
8/3/2026
68.72K→66.34K
Total
Net shares
−15.26K
Net value
-$348.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 7/30/2026 | S · Sale | −4.12K | $22.77 | $93.76K | 5.0% | 81.60K | 77.48K |
| Common Shares Direct | 7/31/2026 | S · Sale | −8.76K | $22.61 | $198K | 11.3% | 77.48K | 68.72K |
| Common Shares Direct | 8/3/2026 | S · Sale | −2.38K | $23.76 | $56.55K | 3.5% | 68.72K | 66.34K |
| Total | −15.26K | -$348.31K | ||||||
Derivative Transactions0
No derivative transactions reported